Organizations Filed Purposes:
CLINICAL RESEARCH FOUNDATION, INC. FACILITATES RESEARCH AT THE ROBLEY REX V MEDICAL CENTER(RRVAMC) IN LOUISVILLE, KY BY PROVIDING A MECHANISM FOR RRVAMC RESEARCHERS TO PARTICIPATE IN RESEARCH PROGRAMS INCLUDING CLINICAL TRIALS THAT ARE FUNDED BY PRIVATE RO NON-VA PUBLIC SOURCES.
CLINICAL RESEARCH FOUNDATION, INC. (CRF) PROMOTES QUALITY SCIENTIFIC RESEARCH TO IMPROVE THE MEDICAL TREATMENT, GENRAL HEALTH AND QUALITY OF LIFE FOR OUR NATIONS VETERANS BY PROVIDING A FLEXIBLE FUNDING MECHANISM TO ROBLEY REX VA MEDICAL CENTER RESEARCHERS FOR NON-VA FUNDED STUDIES OR TRIALS.
INFECTIOUS DISEASE PROGRAM - 123,510 PI: RAMIREZ, JULIO, MD & BURNS, MARK, MD (RAMIR, BURCLO) INFECTIOUS DISEASES ARE DISORDERS CAUSED BY ORGANISMS SUCH AS BACTERIA, VIRUSES, FUNGI OR PARASITES AND A SOURCE OF SIGNIFICANT ILLNESS IN THE VETERAN POPULATION. THE PURPOSE OF THESE STUDIES WAS TO PROVIDE THE LOUISVILLE VA MEDICAL CENTER A BETTER UNDERSTANDING OF THE SIGNIFICANCE OF STREPTOCOCCAL PNEUMONIA IN THEIR PATIENT POPULATION. SPECIFICALLY, THE STUDY WILL ESTIMATE THE PORTION OF RADIO-GRAPHICALLY CONFIRMED COMMUNITY- ACQUIRED PNEUMONIA (CAP) IN ADULTS AGED 18 YEARS AND OLDER WHICH IS DUE TO STREPTOCOCCUS PNEUMONIA AND TO ESTIMATE THE DISTRIBUTION OF 13 DIFFERENT S. PNEUMONIA SEROTYPES IN THIS POPULATION. THIS WILL HELP DETERMINE EARLY AND LATE IMPROVEMENTS OR POSSIBLE COMPLICATIONS AND THEIR FREQUENCY IN HOSPITALIZED ADULT PATIENTS WITH PNEUMONIA TO ADDRESS SOME OF THE GAPS IN CURRENT KNOWLEDGE. ADDITIONAL WORK IS BEING DONE TO TEST THE EFFICACY OF THE PFIZER COVID-19 VACCINE.
DIABETES & CARDIOVASCULAR DISEASE PROGRAM - 64,409 PI: KRISHNASAMY, SATHYA, MD (KRISPROM, KRISSEL & KRISSOUL) DIABETES AND RELATED CARDIOVASCULAR DISEASES ARE A MAJOR CAUSE OF MORBIDITY AND MORTALITY AMONG VETERANS. THE PROMINENT STUDY (KRISPROM) IS TARGETED TO REDUCE CARDIOVASCULAR EVENTS BY REDUCING TRIGLYCERIDES IN DIABETIC VETERANS THROUGH TREATMENT WITH PEMAFIBRATE. THE SELECT STUDY IS DESIGNED TO MEASURE THE EFFECTS ON CARDIOVASCULAR OUTCOMES IN OVERWEIGHT OR OBESE VETERANS. THE SOUL STUDY IS TO DEMONSTRATE THAT ORAL SEMAGLUTIDE LOWERS THE RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS COMPARED TO PLACEBO, BOTH ADDED TO STANDARD CARE IN PATIENTS WITH TYPE 2 DIABETES AND AT HIGH RISK OF CARDIOVASCULAR EVENTS.
GASTROINTESTINAL DISEASE PROGRAM - 13,630 PI: DRYDEN, GERALD, MD, PHD (DRYVIV) GASTROINTESTINAL DISEASES (ABBREV. GI DISEASES OR GI ILLNESSES) REFER TO DISEASES INVOLVING THE GASTROINTESTINAL TRACT, NAMELY THE OESOPHAGUS, STOMACH, SMALL INTESTINE, LARGE INTESTINE AND RECTUM, AND THE ACCESSORY ORGANS OF DIGESTION, THE LIVER, GALLBLADDER, AND PANCREAS. GI DISEASES AND ILLNESSES HAVE A SIGNIFICANT IMPACT ON THE VETERAN POPULATION. THE PURPOSE OF THIS STUDY IS TO EVALUATE THE SAFETY AND EFFICACY OF MIRIKIZUMAB IN ACHIEVING ENDOSCOPIC AND CLINICAL OUTCOMES UP TO WEEK 52 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Michael Book Phd | EXECUTIVE DI | 24 | $41,692 |
| Bill Seiller | DIRECTOR | 1 | $0 |
| Gerald Dryden Md Phd | CHAIR | 2 | $0 |
| Sathya Krishnasamy Md | DIRECTOR | 1 | $0 |
| John Wilson Md | STATUTORY DI | 1 | $0 |
| Belinda Setters Md | DIRECTOR | 1 | $0 |
| Stephen Black Fache | STATUTORY DI | 1 | $0 |
| Greg Bethards | DIRECTOR | 1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202121249349300702_public.xml